Hetero launches generic bevacizumab in India

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

July 12, 2024

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

July 12, 2024

Vol.50 No.28

By Matthew Bin Han Ong

Cancer History Project

“If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor

Christy Erickson was seven years old when her mom lost a three-year battle with breast cancer.

July 12, 2024

Vol.50 No.28

By McKenzie Prillaman

In the Archives

Jänne, Ramalingam, Yu, Winn, Williams, Legg discuss today’s challenges in EGFR research at Yale SPORE workshop

Two decades after uncovering the role of EGFR mutations in lung cancer, scientists are still grappling with lingering research questions.

July 12, 2024

Vol.50 No.28

In Brief

Lei Zheng named executive director of Mays Cancer Center

Lei Zheng was named executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and vice president for oncology for the University of Texas Health Science Center at San Antonio.

July 12, 2024

Vol.50 No.28

In Brief

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Mark Burkard was named director of University of Iowa Health Care Holden Comprehensive Cancer Center.

July 12, 2024

Vol.50 No.28

Hetero launches generic bevacizumab in India

YOU MAY BE INTERESTED IN

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

“If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor

Jänne, Ramalingam, Yu, Winn, Williams, Legg discuss today’s challenges in EGFR research at Yale SPORE workshop

Lei Zheng named executive director of Mays Cancer Center

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Renew today!

Subscriber content

Login

Hetero launches generic bevacizumab in India

YOU MAY BE INTERESTED IN

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

Infections are a major cause of death in patients treated with CAR T-cell therapyMeta-analysis focused on causes of death, excluding relapse, recurrence

“If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor

Jänne, Ramalingam, Yu, Winn, Williams, Legg discuss today’s challenges in EGFR research at Yale SPORE workshop

Lei Zheng named executive director of Mays Cancer Center

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Login

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence